Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 3/20 | 1.00 |
| ▸ | ERN1 | O75460 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | CRHBP | P24387 | 1/20 | 0.57 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.51 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11228321 | 0.97 | GPR35 (0.95) | GPR35ERN1TDP1CRHBPCRHR2 | |
| SCHEMBL30135314 | 0.97 | GPR35 (0.95) | GPR35ERN1TDP1CRHBPCRHR2 | |
| SCHEMBL11228314 | 0.97 | GPR35 (0.95) | GPR35ERN1TDP1CRHBPCRHR2 | |
| SCHEMBL70167 | 0.88 | GPR35 (0.78) | GPR35ERN1TDP1CRHBPCRHR2 | |
| SCHEMBL11309776 | 0.88 | GPR35 (0.78) | GPR35ERN1TDP1CRHBPCRHR2 | |
| SCHEMBL4071134 | 0.86 | GPR35 (0.75) | GPR35ERN1TDP1CRHBPCRHR2 | |
| Toluene SCHEMBL28998637 | 0.85 | GPR35 (0.73) | GPR35ERN1TDP1CRHBPCRHR2 | |
| SCHEMBL846242 | 0.84 | GPR35 (0.72) | GPR35ERN1TDP1CRHBPCRHR2 | |
| SCHEMBL103754 | 0.84 | GPR35 (0.72) | GPR35ERN1TDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL102078 | 0.84 | GPR35 (0.72) | GPR35ERN1TDP1CRHBPCRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 902 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070479-A | Ultrasonic indicating device and method for monitoring ultrasonic treatment | JP实验室股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-20260108476-A1 | 2,4 DNP and Prodrugs Thereof for Treatment of Cancer | MITOCHON PHARMACEUTICALS, INC. (US) | 2026-04-23 | — | — | US | claimed |
| WO-2025090061-A1 | ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION | JP LABORATORIES, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025075611-A1 | ULTRASONIC INDICATOR BASED ON EMULSION FORMATION | JP LABORATORIES, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| CN-118010870-A | Method for simultaneously measuring multiple nitrophenol compounds in different food matrixes | 四川省食品检验研究院 | 2024-05-10 | — | — | CN | claimed |
| WO-2023205625-A2 | 2,4 DNP AND PRODRUGS THEREOF FOR TREATMENT OF PULMONARY AND AUTOIMMUNE DISEASES | MITOCHON PHARMACEUTICALS, INC. (US) | 2023-10-26 | — | — | WO | claimed |
| CN-114235541-B | Method for rapidly determining 12 nitrophenol compounds in industrial wastewater | 甘肃中商食品质量检验检测有限公司 | 2023-09-22 | — | — | CN | claimed |
| WO-2023092175-A1 | NOVEL P2X7 RECEPTOR ANTAGONISTS | THE UNIVERSITY OF SYDNEY (AU) | 2023-06-01 | — | — | WO | claimed |
| US-11629373-B2 | Compositions, systems, and methods for detecting the presence of polymer subunits using chemiluminescence | ILLUMINA, INC. (US) | 2023-04-18 | — | — | US | claimed |
| US-20230100940-A1 | DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases | MITOCHON PHARMACEUTICALS, INC. (US) | 2023-03-30 | — | — | US | claimed |
| EP-0352489-B1 | USE OF 2,6-DINITROPHENOL DERIVATIVES IN HAIR DYEING COMPOSITIONS | Wella Aktiengesellschaft (DE) | 1992-06-17 | — | — | EP | claimed |
| EP-0244799-B1 | AN ELECTROLYTE FOR ELECTROLYTIC CAPACITOR | NIPPON CHEMI-CON CORPORATION (JP) | 1991-03-06 | — | — | EP | claimed |
| US-4975093-A | Hair dyeing compositions containing 2,6-dinitro-phenol-derivatives | WELLA AKTIENGESELLSCHAFT (DE) | 1990-12-04 | — | — | US | claimed |
| US-4830785-A | ALKYL AMMONIUM OR AMINE SALTS OF PHENOL OR NITROPHENOL IN APROTIC SOLVENTS | NIPPON CHEMI-CON CORPORATION (JP) | 1989-05-16 | — | — | US | claimed |
| US-4724234-A | ADMINISTERING NUTRITIONAL REGIMEN AND AGENTS WHICH UNCOUPLE OXIDATIVE PHOSPHORYLATION | THERAPEUTICAL SYSTEMS CORP. (US) | 1988-02-09 | — | — | US | claimed |
| US-4724230-A | Method for producing oncolysis | THERAPEUTICAL SYSTEMS CORP. (US) | 1988-02-09 | — | — | US | claimed |
| EP-0244799-A2 | An electrolyte for electrolytic capacitor | NIPPON CHEMI-CON CORPORATION (JP) | 1987-11-11 | — | — | EP | claimed |
| US-4460717-A | COATING FOUNDRY AGGREGATE WITH PHENOLIC RESIN CONTAINING AN AROMATIC COMPOUND | SUMITOMO DUREZ COMPANY, LTD. (JP) | 1984-07-17 | — | — | US | claimed |
| US-4170669-A | ACID- OR BASE-SOLUBILE | OKADA ICHIRO (JP) | 1979-10-09 | — | — | US | claimed |
| US-4115652-A | Process for the preparation of amino-nitrophenols | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230100940-A1 | DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases | SMN1; SMN2, MYLK2, WFS1 | GPR35 2363/4885ERN1 4205/4885TDP1 42/4885 |
| US-20260108476-A1 | 2,4 DNP and Prodrugs Thereof for Treatment of Cancer | DNPH1, SLC5A2, DNPEP | GPR35 2262/4885ERN1 4620/4885TDP1 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.